Trade Names: | |
Synonyms: | |
Status: | Approved (1993) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | W31X2H97FB |
InChI Key | NGBFQHCMQULJNZ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H20N4O3S |
Molecular Weight | 348.43 |
AlogP | 2.53 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 100.19 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 24.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Sodium-(potassium)-chloride cotransporter 2 inhibitor | DailyMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | - | - | - | 14 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 73 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Heart Failure | 4 | D006333 | ClinicalTrials |
Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 56211-40-6 |
ChEBI | 9637 |
ChEMBL | CHEMBL1148 |
DrugBank | DB00214 |
DrugCentral | 2708 |
EPA CompTox | DTXSID2023690 |
FDA SRS | W31X2H97FB |
Human Metabolome Database | HMDB0014359 |
Guide to Pharmacology | 7312 |
PharmGKB | PA451733 |
PubChem | 41781 |
SureChEMBL | SCHEMBL41184 |
ZINC | ZINC000000005823 |